Interpace Diagnostics

View the org chart displaying its 4 main executives

Most searched biographies at Interpace Diagnostics

• Thomas Burnell, President, Chief Executive Officer and Director
• Syd Finkelstein, Chief Scientific Officer
• Jody Campbell, Chief Revenue Officer

Create your alert
to follow the executive moves at Interpace Diagnostics.

Interpace Diagnostics has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Interpace Diagnostics

• Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
• Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
• Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
• Interpace Biosciences Releases Preliminary Record Second Quarter 2023 Business Results; Updates Status of PancraGEN® Reimbursement
• Interpace Expects to Stop Offering PancraGEN® Test Due to CMS Decision to End Reimbursement as of July 17, 2023
• Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
• Interpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business Results
• Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern
• Interpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual Meeting
• Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved
• View more press releases Close

Social media about Interpace Diagnostics

• Interpace Diagnostics on Wikipedia, Google News & Yahoo Finance
• Interpace Diagnostics on LinkedIn, Twitter & YouTube

Contact by email its executives including Thomas Burnell

Call Interpace Diagnostics at +1 855...

View the org chart

Register to receive your alert

Report an error